Suptavumab Antibody
Suptavumab (REGN2222) is a human monoclonal antibody that neutralizes respiratory syncytial virus (RSV) by targeting conserved epitopes on subtypes A and B. It is a valuable research tool for studying RSV pathogenesis and evaluating antiviral strategies in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
Suptavumab, RSV, REGN2222, REGN-2222, REGN 2222
Target
RSV
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Concentration
3.15 mg/mL
Purity
96.40% (May vary between batches)
Molecular Weight
146.04 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15161160 1 Vial
Lentiviral human FBXO4 shRNA (UAS) - Lentiviral human FBXO4 shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details I7663-25D1A-ML490 100 µL
Interleukin 1 Receptor Type I (Interleukin Receptor 1, IL-1R-1, IL1R1, IL-1RT1, IL1RT1, Interleukin 1 Receptor alpha Type 1, IL-1R alpha, IL1RA, Antigen CD121a, CD121A, CD121a Antigen, D2S1473, IL-1R1, IL1 Inhibitor, P80) (MaxLight 490) discontinued
Sign In for Pricing
View Details